Technical Analysis for ABVC - ABVC Biopharma, Inc.

Grade Last Price % Change Price Change
C 3.1752 1.12% 0.04
ABVC closed down 4.56 percent on Tuesday, January 18, 2022, on 16 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down
Historical ABVC trend table...

Date Alert Name Type % Chg
MACD Bearish Centerline Cross Bearish 1.12%
1,2,3 Pullback Bullish Bullish Swing Setup 1.12%
Narrow Range Bar Range Contraction 1.12%
Stochastic Reached Oversold Weakness 1.12%
Down 3 Days in a Row Weakness 1.12%
Gapped Down Weakness 1.12%
Lower Bollinger Band Touch Weakness 1.12%
Oversold Stochastic Weakness 1.12%
50 DMA Resistance Bearish -3.49%
Fell Below 20 DMA Bearish -4.65%
Older End-of-Day Signals for ABVC ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 2% 12 minutes ago
60 Minute Opening Range Breakout about 1 hour ago
Up 1% about 1 hour ago
Lower Bollinger Band Support about 1 hour ago
Fell Below Previous Day's Low about 1 hour ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

ABVC Biopharma, Inc. Description

American BriVision (Holding) Corporation, a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, a combination therapy for triple negative breast cancer; ABV-1504 for major depressive disorders; ABV-1505 for attention deficit hyperactivity disorder; ABV-1703 for the treatment of pancreatic cancer; ABV-1702 to treat myelodysplastic syndromes; ABV-1601 for treating depression in cancer patients; and ABV-1701 Vitargus for the treatment of retinal detachment or vitreous hemorrhage. It has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company was incorporated in 2015 and is based in Fremont, California. American BriVision (Holding) Corporation is a subsidiary of YuanGene Corporation.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Pancreatic Cancer Major Depressive Disorder Depression Myelodysplastic Syndrome Attention Deficit Hyperactivity Disorder Triple Negative Breast Cancer Treatment Of Pancreatic Cancer

Is ABVC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 11.6883
52 Week Low 1.955
Average Volume 452,528
200-Day Moving Average 0.00
50-Day Moving Average 3.39
20-Day Moving Average 3.54
10-Day Moving Average 3.44
Average True Range 0.28
ADX 40.09
+DI 29.02
-DI 21.10
Chandelier Exit (Long, 3 ATRs) 3.21
Chandelier Exit (Short, 3 ATRs) 3.93
Upper Bollinger Bands 3.97
Lower Bollinger Band 3.12
Percent B (%b) 0.02
BandWidth 23.76
MACD Line -0.01
MACD Signal Line 0.04
MACD Histogram -0.0481
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.32
Resistance 3 (R3) 3.32 3.27 3.29
Resistance 2 (R2) 3.27 3.22 3.26 3.28
Resistance 1 (R1) 3.20 3.19 3.18 3.20 3.27
Pivot Point 3.15 3.15 3.13 3.15 3.15
Support 1 (S1) 3.08 3.10 3.06 3.08 3.01
Support 2 (S2) 3.03 3.07 3.03 3.00
Support 3 (S3) 2.97 3.03 2.99
Support 4 (S4) 2.96